or Try an Advanced Search...

    Technical Analysis for MGRX - Mangoceuticals, Inc.

    Grade Last Price % Change Price Change
    F 2.31 -3.35% -0.08
    MGRX closed down 3.35 percent on Friday, November 15, 2024, on 16 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical MGRX trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    BB Squeeze + Lower Band Touch Range Contraction 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Fell Below 20 DMA Bearish -3.35%
    Bollinger Band Squeeze Range Contraction -3.35%
    Narrow Range Bar Range Contraction -3.35%
    Down 3 Days in a Row Weakness -3.35%
    Older End-of-Day Signals for MGRX ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Resistance 1 day ago
    10 DMA Resistance 1 day ago
    Down 5% 1 day ago
    Down 3% 1 day ago
    Fell Below Lower Bollinger Band 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    MGRX Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
    Classification
    Sector: Healthcare
    Industry: Health Information Services
    Keywords: Telehealth Telemedicine Wellness Products Erectile Dysfunction

    Is MGRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
    Oct 22 MangoRx Announces Formation of Strategy and Alternatives Committee
    Oct 21 Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit
    Oct 21 MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
    Oct 18 Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024
    Oct 11 Mangoceuticals announces 1-for-15 reverse stock split
    Oct 11 MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN
    Oct 3 MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
    Oct 1 MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment
    Aug 17 Mangoceuticals Second Quarter 2024 Earnings: US$0.092 loss per share (vs US$0.14 loss in 2Q 2023)
    See more MGRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 16.8
    52 Week Low 2.1
    Average Volume 443,932
    200-Day Moving Average 4.12
    50-Day Moving Average 3.06
    20-Day Moving Average 2.40
    10-Day Moving Average 2.40
    Average True Range 0.25
    RSI (14) 40.83
    ADX 16.68
    +DI 21.70
    -DI 19.75
    Chandelier Exit (Long, 3 ATRs) 2.07
    Chandelier Exit (Short, 3 ATRs) 2.86
    Upper Bollinger Bands 2.53
    Lower Bollinger Band 2.28
    Percent B (%b) 0.11
    BandWidth 10.14
    MACD Line -0.19
    MACD Signal Line -0.23
    MACD Histogram 0.0478
    Fundamentals Value
    Market Cap 50.87 Million
    Num Shares 22 Million
    EPS -0.44
    Price-to-Earnings (P/E) Ratio -5.25
    Price-to-Sales 12.35
    Price-to-Book 6.49
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.54
    Resistance 3 (R3) 2.55 2.48 2.50
    Resistance 2 (R2) 2.48 2.43 2.48 2.48
    Resistance 1 (R1) 2.40 2.39 2.37 2.39 2.47
    Pivot Point 2.33 2.33 2.32 2.33 2.33
    Support 1 (S1) 2.25 2.28 2.22 2.24 2.15
    Support 2 (S2) 2.18 2.24 2.18 2.14
    Support 3 (S3) 2.10 2.18 2.12
    Support 4 (S4) 2.09